Pay in 4 interest-free payments of $49.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
=98% (HPLC)
In vitro and in vivo delivery of a sustained releasenanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22
PubMed Central PMCID: PMC4443583
CPI-169 selectively affects the turnover of trimethylated
CCT365623 HCl - CAS# 2126136-98-7 035 =98% (HPLC)CCT365623 HCl, CAS No. 2126136 98 7, is a Lysyl oxidase inhibitor. CCT365623 disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumour cells in vivo. LOX regulates EGFR cell surface retention to drive tumour progression. Product information CAS Number: 2126136 98 7 Molecular Weight: 443. 99 Formula: C18H18ClNO4S3 Chemical Name: C [5 (5 Methanesulfonyl biphenyl 3 sulfonyl) thiophen 2 yl] methylamine Hydrochloride